Kann, Peter H.
Bergmann, Simona
Bidlingmaier, Martin
Dimopoulou, Christina
Pedersen, Birgitte T.
Stalla, Günter K.
Weber, Matthias M.
Meckes-Ferber, Stefanie
Funding for this research was provided by:
Novo Nordisk Pharma GmbH
Article History
Received: 13 September 2017
Accepted: 1 February 2018
First Online: 13 February 2018
Ethics approval and consent to participate
: This study was performed in accordance with the Declaration of Helsinki. Ethical permissions were obtained from the Ethical Commission of the Chamber of Physicians of the German Federal State of Hessia (reference no FF 22/2009).Written and informed consent for the registration and transfer of their personal data was obtained from all patients.
: Not applicable.
: PHK has received research funding, honoraria for lectures and is a member of scientific boards for Novo Nordisk and Pfizer. MB has received research support, consultancy fees and/or speakers honoraria from Novo Nordisk, Pfizer, Sandoz, Novartis, IPSEN, OPKO and Genexine. BTP is an employee of Novo Nordisk A/S, Denmark. GKS has received speaker fees from Novo Nordisk and study investigator sponsored by Novo Nordisk. MMW is member of the NordiNet® ISC Board Novo Nordisk. SM-F is an employee and stockholder of Novo Nordisk Pharma GmbH, Germany. SB and CD have no conflicts of interest to declare.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.